![Olanrewaju Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olanrewaju Smith
Chairman at Global Alliance for Livestock Veterinary Medicines
Network origin in Olanrewaju Smith first degree
Entity | Entity type | Industry | |
---|---|---|---|
Global Alliance for Livestock Veterinary Medicines
![]() Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries.
11
| Non-Profit Organization | Miscellaneous Commercial Services | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Olanrewaju Smith via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Elanco Tiergesundheit AG
![]() Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Intervet International BV
![]() Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Pharmaceuticals: Major | Sales & Marketing | |
Novavax AB
![]() Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
The University of Nottingham | College/University | Doctorate Degree | |
The Moredun Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Jenner Vaccine Foundation | Director/Board Member |
Statistics
International
United Kingdom | 4 |
United States | 2 |
Switzerland | 2 |
Netherlands | 2 |
Sweden | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Miscellaneous | 2 |
Operational
Director/Board Member | 11 |
Chief Tech/Sci/R&D Officer | 2 |
Sales & Marketing | 1 |
Chairman | 1 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Peter Wells | 6 |
Paul van Aarle | 2 |
Paul Dominowski | 2 |
Mark Rweyemamu | 1 |
Julian Ince | 1 |
Carolin Schumacher | 1 |
William Amanfu | 1 |
Paul Wood | 1 |
Krishan Pathak | 1 |
Margaret Gill | 1 |
Peter Jeffries | 1 |
- Stock Market
- Insiders
- Olanrewaju Smith
- Company connections